Real-World Data Show Total Neoadjuvant Therapy Boosts Tumor Response in Rectal Cancer
A large real-world cohort from Thailand finds that total neoadjuvant therapy doubles pathological complete response rates in locally advanced rectal ...
A large real-world cohort from Thailand finds that total neoadjuvant therapy doubles pathological complete response rates in locally advanced rectal ...
A Dutch proof-of-concept trial shows that a CEA-targeted fluorescent agent can make hidden high-grade dysplasia and early invasive rectal cancer ...
China's leading colorectal cancer surgical experts have issued a comprehensive 2025 national consensus codifying how robotic surgery for colorectal cancer ...
A long-term Japanese cohort study found that 87 percent of rectal cancer patients treated with radiation-based neoadjuvant therapy remained stoma-free ...
A nationwide Japanese cohort study of 5458 colorectal cancer patients found that laparoscopic surgery was associated with a significantly lower ...
A new review argues that neoadjuvant chemoradiotherapy may induce immune checkpoint blockade responsiveness in mismatch repair-proficient rectal cancer, with sequential ...
New TORCH trial data show that combining SMAD4 mutation status, tumor mutational burden, and serial ctDNA with MRI assessments substantially ...
A nationwide Japanese study finds robotic rectal surgery surged after 2018 insurance coverage but remains significantly concentrated in urban prefectures.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine